Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
Neurology|March 28, 2020
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive declineJoanne Ryan, Elsdon Storey, Anne M Murray, et al.
Neurology|January 29, 2025
Association of Year-to-Year Lipid Variability With Risk of Cognitive Decline and Dementia in Community-Dwelling Older AdultsZhen Zhou, Chris Moran, Anne M Murray, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 1, 2023
Low-Density-Lipoprotein Cholesterol and Mortality Outcomes Among Healthy Older Adults: A Post Hoc Analysis of ASPREE TrialZhen Zhou, Andrew M Tonkin, Andrea J Curtis, et al.
Circulation|October 22, 2025
Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE TrialAnping Cai, Antoni Bayes-Genis, Joanne Ryan, et al.
Alzheimer'S Research & Therapy|May 18, 2024
The impact of incident stroke on cognitive trajectories in later lifeSwarna Vishwanath, Ingrid Hopper, Geoffrey C Cloud, et al.
Hepatology Communications|June 27, 2025
Prevalence and outcomes of steatotic liver disease subtypes in older adultsDaniel Clayton-Chubb, Ammar Majeed, Isabella Commins, et al.
JAMA Network Open|April 20, 2026
Cognitive Decline Preceding Incident Cardiovascular Events in Older AdultsSwarna Vishwanath, Zimu Wu, Andrew Tonkin, et al.
The Lancet. Healthy Longevity|October 3, 2025
Aspirin and healthy lifespan in older people: main outcome of the ASPREE-XT observational studyRaj C Shah, Joanne Ryan, Katherine L Webb, et al.
Age and Ageing|September 18, 2025
The association of retinal vessel calibre, white matter hyperintensities and cognitive decline in community-dwelling older adultsCatherine Robb, Amy Brodtmann, Robyn L Woods, et al.
JAMA Cardiology|October 15, 2025
Clonal Hematopoiesis and Cardiovascular Disease and Bleeding Risk and the Effectiveness of AspirinZoe K McQuilten, Le T P Thao, Alexander G Bick, et al.
Pageof 26